Ifp Advisors, Inc Oragenics Inc Transaction History

Ifp Advisors, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.11 - $15.59 $11 - $1,559	-100 Reduced 50.0%	100 $1,000
Q3 2022 Nov 08, 2022	BUY	$0.23 - $14.18 $46 - $2,836	200 New	200 $1,000
Q3 2021 Oct 06, 2021	SELL	$0.58 - $0.84 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$0.6 - $0.89 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$0.52 - $1.52 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$0.39 - $0.6 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$0.56 - $1.49 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$0.39 - $0.83 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$0.43 - $0.75 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$0.42 - $0.62 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$0.36 - $0.64 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$0.57 - $1.05 $1,764 - $3,250	-3,096 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$1.6 - $3.17 $4,953 - $9,814	3,096 New	3,096 $0

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $41.9M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.